Elevance Health Inc. (ANTM)

Growth

Revenue 5Y11.92%
Revenue 3Y16.44%
EPS 5Y21.58%
EPS 3Y19.52%
Dividend 5Y11.65%
Dividend 3Y14.27%

Capital Efficiency

ROIC2.80%
ROE17.00%
ROA6.05%
ROTA6.77%

Capital Structure

Market Cap116.34B
EV133.47B
Cash6.46B
Current Ratio2.20
Debt/Equity0.64
Net Debt/EBITDA1.68
Show More

Income Statement

Select a metric from the list below to chart it

Dec '98
Dec '03
Dec '08
Dec '13
Dec '18
Income Statement
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Revenue
71,023.5
73,874.1
79,156.5
84,863.0
90,039.4
92,105.0
104,213.0
121,867.0
138,639.0
149,130.0
Revenue % Chg.
15.1%
4.0%
7.2%
7.2%
6.1%
2.3%
13.1%
16.9%
13.8%
15.4%
Selling, General, & Admin Expenses
9,952.9
11,748.4
12,534.8
12,557.9
12,649.6
14,020.0
13,364.0
17,450.0
15,914.0
16,778.0
Selling, General, & Admin Expenses % Chg.
13.9%
18.0%
6.7%
0.2%
0.7%
10.8%
-4.7%
30.6%
-8.8%
-3.4%
Other Expenses
56,482.1
57,075.6
61,347.2
67,027.1
72,405.4
72,253.0
84,116.0
-
-
-
Other Expenses % Chg.
16.7%
1.1%
7.5%
9.3%
8.0%
-0.2%
16.4%
-
-
-
Total Other Income/Expenses Net
40.4
41.3
43.1
35.1
33.1
-
-
10,384.0
436.0
-
Total Other Income/Expenses Net % Chg.
-86.4%
2.2%
4.4%
-18.6%
-5.7%
-
-
-
-95.8%
-
Income Before Tax
3,840.2
4,368.1
4,631.0
4,555.4
3,963.8
5,068.0
5,985.0
6,238.0
7,925.0
7,865.0
Income Before Tax % Chg.
-0.7%
13.7%
6.0%
-1.6%
-13.0%
27.9%
18.1%
4.2%
27.0%
42.2%
Income Before Tax Margin
5.4%
5.9%
5.9%
5.4%
4.4%
5.5%
5.7%
5.1%
5.7%
5.3%
Income Before Tax Margin % Chg.
-13.7%
9.4%
-1.1%
-8.2%
-18.0%
25.0%
4.4%
-10.9%
11.7%
23.3%
Income Tax Expense
1,205.9
1,808.0
2,071.0
2,085.6
121.0
1,318.0
1,178.0
1,666.0
1,830.0
1,793.0
Income Tax Expense % Chg.
-0.3%
49.9%
14.5%
0.7%
-94.2%
989.3%
-10.6%
41.4%
9.8%
39.2%
Net Income
2,489.7
2,569.7
2,560.0
2,469.8
3,842.8
3,750.0
4,807.0
4,572.0
6,104.0
6,104.0
Net Income % Chg.
-6.2%
3.2%
-0.4%
-3.5%
55.6%
-2.4%
28.2%
-4.9%
33.5%
44.3%
Net Income Margin
3.5%
3.5%
3.2%
2.9%
4.3%
4.1%
4.6%
3.8%
4.4%
4.1%
Net Income Margin % Chg.
-18.5%
-0.8%
-7.0%
-10.0%
46.6%
-4.6%
13.3%
-18.7%
17.4%
25.0%
Weighted Avg. Shares Out
293.3
268.1
261.2
263.7
256.1
257.4
252.9
245.4
245.4
241.8
Weighted Avg. Shares Out % Chg.
-3.8%
-8.6%
-2.6%
1.0%
-2.9%
0.5%
-1.7%
-3.0%
-
-1.9%
EPS
8.5
9.6
9.8
9.4
15.0
14.6
19.0
18.6
24.9
25.3
EPS % Chg.
-2.6%
12.9%
2.2%
-4.4%
60.2%
-2.9%
30.5%
-2.0%
33.5%
46.4%
Weighted Avg. Shares Out Dil
303.8
285.9
272.9
268.1
267.8
264.2
260.3
254.3
254.3
244.8
Weighted Avg. Shares Out Dil % Chg.
-6.5%
-5.9%
-4.5%
-1.8%
-0.1%
-1.3%
-1.5%
-2.3%
-
-2.2%
EPS Diluted
8.2
9.0
9.4
9.2
14.4
14.2
18.5
18.0
24.0
24.9
EPS Diluted % Chg.
0.2%
9.6%
4.3%
-1.8%
55.8%
-1.1%
30.2%
-2.7%
33.5%
46.5%
Interest Expense
602.7
600.7
653.0
723.0
739.0
753.0
746.0
784.0
798.0
810.0
Interest Expense % Chg.
17.8%
-0.3%
8.7%
10.7%
2.2%
1.9%
-0.9%
5.1%
1.8%
3.1%
EBIT
3,237.5
3,767.4
3,978.0
3,832.4
3,224.8
4,315.0
5,239.0
5,454.0
7,127.0
7,055.0
EBIT % Chg.
-3.5%
16.4%
5.6%
-3.7%
-15.9%
33.8%
21.4%
4.1%
30.7%
48.7%
EBIT Margin
4.6%
5.1%
5.0%
4.5%
3.6%
4.7%
5.0%
4.5%
5.1%
4.7%
EBIT Margin % Chg.
-16.1%
11.9%
-1.5%
-10.1%
-20.7%
30.8%
7.3%
-11.0%
14.9%
28.9%
Depreciation & Amortization
908.8
851.0
907.9
911.8
890.4
1,132.0
1,133.0
1,154.0
1,302.0
1,462.0
Depreciation & Amortization % Chg.
22.7%
-6.4%
6.7%
0.4%
-2.3%
27.1%
0.1%
1.9%
12.8%
23.0%
EBITDA
4,146.3
4,618.4
4,885.9
4,744.2
4,115.2
5,447.0
6,372.0
6,608.0
8,429.0
8,517.0
EBITDA % Chg.
1.3%
11.4%
5.8%
-2.9%
-13.3%
32.4%
17.0%
3.7%
27.6%
43.6%
EBITDA Margin
5.8%
6.3%
6.2%
5.6%
4.6%
5.9%
6.1%
5.4%
6.1%
5.7%
EBITDA Margin % Chg.
-12.0%
7.1%
-1.3%
-9.4%
-18.2%
29.4%
3.4%
-11.3%
12.1%
24.4%